Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,436,000 | 2,134,000 | 10,081,000 | 4,506,000 | 3,031,000 |
| Marketable Securities | 31,275,000 | 33,212,000 | 22,318,000 | 18,462,000 | 21,275,000 |
| Receivables | 11,523,000 | 12,735,000 | 10,675,000 | 12,523,000 | 12,882,000 |
| Inventories | 6,282,000 | 7,035,000 | 6,076,000 | 7,516,000 | 7,001,000 |
| Income taxes - deferred | N/A | N/A | 6,170,000 | N/A | N/A |
| Other current assets | 9,919,000 | 9,647,000 | 9,511,000 | 14,120,000 | 14,576,000 |
| TOTAL | $61,435,000 | $64,763,000 | $64,831,000 | $57,127,000 | $58,765,000 |
| Non-Current Assets | |||||
| PPE Net | 12,443,000 | 13,950,000 | 13,213,000 | 14,606,000 | 14,756,000 |
| Investments And Advances | 16,107,000 | 15,392,000 | 14,149,000 | 13,429,000 | 10,548,000 |
| Intangibles | 84,207,000 | 87,861,000 | 88,807,000 | 91,579,000 | 92,967,000 |
| Other Non-Current Assets | 5,143,000 | 5,432,000 | 4,798,000 | 5,862,000 | 5,806,000 |
| TOTAL | $117,900,000 | $122,635,000 | $120,967,000 | $125,476,000 | $124,077,000 |
| Total Assets | $179,335,000 | $187,398,000 | $185,798,000 | $182,603,000 | $182,842,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,214,000 | 8,896,000 | 6,424,000 | 7,774,000 | 7,703,000 |
| Accounts payable and accrued liabilities | 1,978,000 | 3,279,000 | 2,921,000 | 2,967,000 | 3,165,000 |
| Accrued Expenses | 1,430,000 | 1,684,000 | 1,875,000 | 1,736,000 | 1,493,000 |
| Other current liabilities | 12,218,000 | 12,521,000 | 13,812,000 | 13,455,000 | 13,215,000 |
| TOTAL | $23,450,000 | $27,543,000 | $29,186,000 | $29,131,000 | $30,798,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,532,000 | 31,481,000 | 31,036,000 | 31,083,000 | 30,868,000 |
| Other Non-Current Liabilities | 22,999,000 | 23,087,000 | 22,699,000 | 21,135,000 | 22,721,000 |
| TOTAL | $76,908,000 | $77,028,000 | $74,934,000 | $71,357,000 | $72,083,000 |
| Total Liabilities | $100,358,000 | $104,571,000 | $104,120,000 | $100,488,000 | $102,881,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,620,300 | 7,093,223 | 7,189,062 | 7,362,573 | 7,469,484 |
| Common Shares | 451,000 | 450,000 | 448,000 | 447,000 | 447,000 |
| Retained earnings | 67,628,000 | 56,972,000 | 54,240,000 | 51,256,000 | 47,904,000 |
| Other shareholders' equity | -5,999,000 | -5,541,000 | -5,496,000 | -5,202,000 | -5,554,000 |
| TOTAL | $78,977,000 | $82,827,000 | $81,678,000 | $82,115,000 | $79,961,000 |
| Total Liabilities And Equity | $179,335,000 | $187,398,000 | $185,798,000 | $182,603,000 | $182,842,000 |